New England Research & Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.12M | Hold |
15,950
| – | – | 0.53% | 66 |
|
2025
Q1 | $1.17M | Buy |
15,950
+9,800
| +159% | +$720K | 0.6% | 57 |
|
2024
Q4 | $403K | Hold |
6,150
| – | – | 0.21% | 114 |
|
2024
Q3 | $479K | Hold |
6,150
| – | – | 0.22% | 112 |
|
2024
Q2 | $480K | Sell |
6,150
-200
| -3% | -$15.6K | 0.23% | 127 |
|
2024
Q1 | $430K | Hold |
6,350
| – | – | 0.21% | 122 |
|
2023
Q4 | $428K | Sell |
6,350
-300
| -5% | -$20.2K | 0.23% | 117 |
|
2023
Q3 | $450K | Hold |
6,650
| – | – | 0.26% | 110 |
|
2023
Q2 | $476K | Hold |
6,650
| – | – | 0.28% | 94 |
|
2023
Q1 | $462K | Sell |
6,650
-200
| -3% | -$13.9K | 0.27% | 108 |
|
2022
Q4 | $464K | Hold |
6,850
| – | – | 0.27% | 110 |
|
2022
Q3 | $376K | Hold |
6,850
| – | – | 0.24% | 117 |
|
2022
Q2 | $453K | Sell |
6,850
-4,700
| -41% | -$311K | 0.26% | 111 |
|
2022
Q1 | $766K | Sell |
11,550
-4,275
| -27% | -$284K | 0.4% | 82 |
|
2021
Q4 | $922K | Sell |
15,825
-4,100
| -21% | -$239K | 0.45% | 72 |
|
2021
Q3 | $1.2M | Buy |
19,925
+3,775
| +23% | +$227K | 0.63% | 55 |
|
2021
Q2 | $967K | Sell |
16,150
-5,200
| -24% | -$311K | 0.5% | 72 |
|
2021
Q1 | $1.06M | Sell |
21,350
-125
| -0.6% | -$6.22K | 0.58% | 63 |
|
2020
Q4 | $1.07M | Buy |
21,475
+15,725
| +273% | +$786K | 0.66% | 54 |
|
2020
Q3 | $315K | Sell |
5,750
-157
| -3% | -$8.6K | 0.23% | 106 |
|
2020
Q2 | $312K | Hold |
5,907
| – | – | 0.22% | 121 |
|
2020
Q1 | $264K | Hold |
5,907
| – | – | 0.23% | 114 |
|
2019
Q4 | $295K | Hold |
5,907
| – | – | 0.2% | 132 |
|
2019
Q3 | $263K | Hold |
5,907
| – | – | 0.19% | 136 |
|
2019
Q2 | $244K | Hold |
5,907
| – | – | 0.17% | 147 |
|
2019
Q1 | $239K | Hold |
5,907
| – | – | 0.16% | 148 |
|
2018
Q4 | $224K | Sell |
5,907
-100
| -2% | -$3.79K | 0.18% | 142 |
|
2018
Q3 | $238K | Hold |
6,007
| – | – | 0.15% | 141 |
|
2018
Q2 | $211K | Hold |
6,007
| – | – | 0.14% | 156 |
|
2018
Q1 | $210K | Sell |
6,007
-1,400
| -19% | -$48.9K | 0.14% | 150 |
|
2017
Q4 | $257K | Sell |
7,407
-9,400
| -56% | -$326K | 0.18% | 128 |
|
2017
Q3 | $569K | Buy |
16,807
+9,657
| +135% | +$327K | 0.42% | 88 |
|
2017
Q2 | $244K | Sell |
7,150
-9,915
| -58% | -$338K | 0.18% | 137 |
|
2017
Q1 | $531K | Sell |
17,065
-2,000
| -10% | -$62.2K | 0.41% | 81 |
|
2016
Q4 | $521K | Buy |
19,065
+12,840
| +206% | +$351K | 0.41% | 81 |
|
2016
Q3 | $205K | Sell |
6,225
-19,525
| -76% | -$643K | 0.17% | 156 |
|
2016
Q2 | $777K | Buy |
+25,750
| New | +$777K | 0.67% | 44 |
|
2015
Q3 | – | Sell |
-6,600
| Closed | -$210K | – | 164 |
|
2015
Q2 | $210K | Hold |
6,600
| – | – | 0.17% | 164 |
|
2015
Q1 | $226K | Hold |
6,600
| – | – | 0.19% | 154 |
|
2014
Q4 | $232K | Buy |
6,600
+500
| +8% | +$17.6K | 0.2% | 160 |
|
2014
Q3 | $218K | Hold |
6,100
| – | – | 0.19% | 158 |
|
2014
Q2 | $227K | Buy |
+6,100
| New | +$227K | 0.2% | 143 |
|